Therapeutic Approaches to the Treatment of Tinnitus

Niklas · Oct 8, 2018

Abstract
Tinnitus is a highly prevalent condition that is associated with hearing loss in most cases. In the absence of external stimuli, phantom perceptions of sounds emerge from alterations in neuronal activity within central auditory and nonauditory structures. Pioneering studies using lidocaine revealed that tinnitus is susceptible to pharmacological interventions. However, lidocaine is not effective in all patients, and no other drug has been identified with clear efficacy for the long-term treatment of tinnitus. In this review, we present recent advances in tinnitus research, including more detailed knowledge of its pathophysiology and involved neurotransmitter systems. Moreover, we summarize results from animal and clinical treatment studies as well as from studies that identified tinnitus as a side effect of pharmacological treatments. Finally, we focus on challenges in the development of pharmacological compounds for the treatment of tinnitus, namely the limitations of available animal models and of standardized clinical research methodologies.
Click to expand...

https://www.annualreviews.org/doi/10.1146/annurev-pharmtox-010818-021556

Log in or Sign up

Therapeutic Approaches to the Treatment of Tinnitus

Niklas Member Benefactor

Comparison of Different Therapeutic Approaches

Modulation of Gut Microbiome as a Therapeutic Modality for Auditory Disorders

Hoba Therapeutics' HB-097 for Sensorineural Hearing Loss

3rd Inner Ear Disorders Therapeutics Summit — August 29-31, 2023 in Boston

Nicotinic Acetylcholine Receptors as Therapeutic Tinnitus Targets

Share This Page

Log in or Sign up

Therapeutic Approaches to the Treatment of Tinnitus

Useful Searches

Niklas Member Benefactor

Comparison of Different Therapeutic Approaches

Modulation of Gut Microbiome as a Therapeutic Modality for Auditory Disorders

Hoba Therapeutics' HB-097 for Sensorineural Hearing Loss

3rd Inner Ear Disorders Therapeutics Summit — August 29-31, 2023 in Boston

Nicotinic Acetylcholine Receptors as Therapeutic Tinnitus Targets

Share This Page